Avinger Announces Publication of Study Demonstrating Positive Clinical Outcomes for Patients Treated with Pantheris Prior to Antirestenotic Therapy
93% Primary Patency Rate and 100% Freedom from Target Lesion Revascularization at 12 Months REDWOOD CITY, CA / ACCESSWIRE /...